John Goll insider trades: Immunocore Holdings (IMCR) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | IMCR | ↓ Sell | 698 | $32.35 | $23K | Direct | Feb 19, 2026 (1d) |
| Nov 18, 2019 | INSM | ↓ Sell | 25,000 | $20.04 | $501K | Direct | Nov 20, 2019 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IMCR insiders
Open-market trades in the last 12 months
About John Goll's insider trades
John Goll is SVP, Finance & CAO at Immunocore Holdings (IMCR). Since Nov 18, 2019, John has reported no open-market purchases and 2 sales worth $524K on SEC Form 4. In the last 12 months: 1 sale ($23K).
Their filings also include grants and awards (4 filings), option exercises (2 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IMCR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.